Article
Microglia: a cellular vehicle for CNS gene therapy
1 Nov 2006
Abstract excerpt
Metachromatic leukodystrophy (MLD) is a lysosomal storage disease caused by deficiency of the enzyme arylsulfatase A (ARSA). MLD is characterized by progressive demyelination and neurological deficits. Treatment of MLD is still a challenge due to the fact that the blood-brain barrier is a major obstacle for most therapeutic substances. In this issue of the JCI, Biffi et al. report that genetically modified...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
